Home › Companies › TWIST BIOSCIENCE CORP. › 2024-2025

TWIST BIOSCIENCE CORP. 2024-2025 Proxy Voting Records

Compiled from SEC Form N-PX filings and TWIST BIOSCIENCE CORP.’s Form 8-K, filed 2025-02-11 (Item 5.07 on EDGAR). Page generated 02 October 2026.

12Reported items
292Asset managers
2,639Fund votes
2025-02-05Meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore TWIST BIOSCIENCE CORP. in the interactive database Compare manager voting policies

Official 2024-2025 meeting results reported by TWIST BIOSCIENCE CORP.

These tallies are TWIST BIOSCIENCE CORP.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2025-02-11 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

TWIST BIOSCIENCE CORP. — official shareholder meeting results, meeting held 2025-02-05
Ballot item	For	Against	Abstain	Withheld	Broker non-votes	Outcome
Elect Director: Nelson C. Chan	33,574,782	--	--	17,243,516	4,537,758	Majority: yes
Elect Director: Robert Ragusa	40,170,187	--	--	10,648,111	4,537,758	Majority: yes
Elect Director: Melissa A. Starovasnik, Ph.D.	48,898,476	--	--	1,919,822	4,537,758	Majority: yes
Proposal Six Amendment of the Charter to Provide for Officer Exculpation The Company's stockholders approved the amendment of the Charter to provide for officer exculpation , by the following votes:	46,462,879	4,323,605	31,814	--	4,537,758	Majority: yes

Source: TWIST BIOSCIENCE CORP., Form 8-K, filed with the SEC on 2025-02-11 — read the filing on EDGAR.

How asset managers voted at the TWIST BIOSCIENCE CORP. 2024-2025 meeting

Each item below shows how the 292 asset managers that disclosed a TWIST BIOSCIENCE CORP. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of TWIST BIOSCIENCE CORP.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. To adopt, on an advisory basis, a resolution approving the compensation of the Company's Named Executive Officers, as described in the Proxy Statement under "Executive Compensation."

COMPENSATION

Combines 11 wordings of this item as funds reported it.

98% fund support · no official result

FOR 98%

The 283 asset managers below cast 98% of the shares they voted on this item FOR (57,847,737 for, 1,290,134 against).

FOR: 57,847,737 (97.8%)AGAINST: 1,290,134 (2.2%)ABSTAIN: 7,249 (0.0%)NOT VOTED: 233 (0.0%)

Largest asset managers voting on “To adopt, on an advisory basis, a resolution approving the compensation of the Company's Named Executive Offic” at TWIST BIOSCIENCE CORP., 2024-2025
Asset manager	For	Against	Vote
Artisan	6,633,127	0	For
Vanguard	5,845,145	0	For
ARK ETF Trust	5,467,381	0	For
Invesco	4,894,857	0	For
BlackRock	3,407,957	0	For
Thrivent	2,997,411	0	For
State Street	2,808,590	0	For
Nikko Asset Management Co., Ltd.	2,626,043	0	For
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC	2,352,225	0	For
Fidelity	1,721,756	0	For
GEODE CAPITAL MANAGEMENT, LLC	1,374,045	0	For
American Century	1,224,370	0	For
Charles Schwab	1,083,898	0	For
Citadel	910,687	0	For
First Light Asset Management, LLC	857,427	0	For
FRED ALGER MANAGEMENT, LLC	768,788	0	For
JPMorgan	733,666	0	For
Bridge Builder Trust	692,439	0	For
ALGER FUNDS	658,990	0	For
WILLIAM BLAIR FUNDS	643,399	0	For
Victory Capital	620,747	0	For
Dimensional	567,662	0	For
JENNISON ASSOCIATES LLC	555,609	0	For
BAILLIE GIFFORD & CO LTD	463,665	0	For
NEW YORK STATE COMMON RETIREMENT FUND	0	452,622	Against

Showing the 25 largest of 283 asset managers. See all 283 in the interactive database.

2. To approve an amendment and restatement of the Company's 2018 Equity Incentive Plan (the "EIP") to increase the number of shares of common stock reserved for issuance of awards under the EIP, eliminate the "evergreen" provision and make other amendments.

COMPENSATION

Combines 3 wordings of this item as funds reported it.

98% fund support · no official result

FOR 98%

The 84 asset managers below cast 98% of the shares they voted on this item FOR (28,931,874 for, 722,253 against).

FOR: 28,931,874 (97.5%)AGAINST: 722,253 (2.4%)ABSTAIN: 7,164 (0.0%)

Largest asset managers voting on “To approve an amendment and restatement of the Company's 2018 Equity Incentive Plan (the "EIP") to increase th” at TWIST BIOSCIENCE CORP., 2024-2025
Asset manager	For	Against	Vote
Vanguard	5,604,178	0	For
ARK ETF Trust	5,467,381	0	For
Invesco	2,265,036	0	For
BlackRock	1,975,800	0	For
Artisan	1,940,297	0	For
Fidelity	1,496,978	0	For
Thrivent	1,492,461	0	For
First Light Asset Management, LLC	857,427	0	For
State Street	816,097	86	For
JPMorgan	725,666	0	For
Bridge Builder Trust	680,400	12,039	For
ALGER FUNDS	658,990	0	For
WILLIAM BLAIR FUNDS	643,399	0	For
American Century	0	598,483	Against
Charles Schwab	541,843	0	For
Dimensional	453,797	0	For
Jackson National	425,440	0	For
TIAA	247,992	0	For
BNY Mellon	242,641	0	For
Victory Capital	210,512	0	For
OPTIMUM FUND TRUST	202,500	0	For
MassMutual	195,723	0	For
AIG/SunAmerica	167,303	0	For
Equitable	158,218	0	For
Voya	114,490	0	For

Showing the 25 largest of 84 asset managers. See all 84 in the interactive database.

3. To approve an amendment to the Charter to provide for officer exculpation.

CORPORATE GOVERNANCEMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

91% Majority: yes · of votes cast

FOR 91%9%

FOR: 46,462,879AGAINST: 4,323,605

TWIST BIOSCIENCE CORP.’s own tally for this item (“Proposal Six Amendment of the Charter to Provide for Officer Exculpation The Company's stockholders approved the amendment of the Charter to provide for officer exculpation , by the following votes:”): 46,462,879 for, 4,323,605 against, per its Form 8-K filed 2025-02-11 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 59,582,000 outstanding shares: 78% for, 7% against (85% of the company cast a for/against vote).

The 83 asset managers below cast 97% of the shares they voted on this item FOR (27,997,195 for, 1,003,659 against).

FOR 97%

FOR: 27,997,195 (96.5%)AGAINST: 1,003,659 (3.5%)ABSTAIN: 7,164 (0.0%)

Largest asset managers voting on “To approve an amendment to the Charter to provide for officer exculpation.” at TWIST BIOSCIENCE CORP., 2024-2025
Asset manager	For	Against	Abstain	Vote
Vanguard	5,604,178	0	0	For
ARK ETF Trust	5,467,381	0	0	For
Invesco	2,265,036	0	0	For
BlackRock	1,975,800	0	0	For
Artisan	1,940,297	0	0	For
Fidelity	1,496,978	0	0	For
Thrivent	1,492,461	0	0	For
State Street	816,097	86	0	For
JPMorgan	0	725,666	0	Against
Bridge Builder Trust	680,400	12,039	0	For
ALGER FUNDS	658,990	0	0	For
WILLIAM BLAIR FUNDS	643,399	0	0	For
American Century	598,483	0	0	For
Charles Schwab	541,843	0	0	For
Dimensional	453,797	0	0	For
Jackson National	425,440	0	0	For
TIAA	247,992	0	0	For
BNY Mellon	242,641	0	0	For
Brighthouse	214,534	0	7,164	For
Victory Capital	210,512	0	0	For
OPTIMUM FUND TRUST	202,500	0	0	For
MassMutual	195,723	0	0	For
AIG/SunAmerica	167,303	0	0	For
Equitable	158,218	0	0	For
Voya	114,490	0	0	For

Showing the 25 largest of 83 asset managers. See all 83 in the interactive database.

4. Election of Class I Directors: Nelson Chan

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 6 wordings of this item as funds reported it.

66% Majority: yes · of votes cast

FOR 66%WITHHELD 34%

FOR: 33,574,782WITHHELD: 17,243,516

TWIST BIOSCIENCE CORP.’s own tally for this item (“Elect Director: Nelson C. Chan”): 33,574,782 for, 17,243,516 withheld, per its Form 8-K filed 2025-02-11 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 59,582,000 outstanding shares: 56% for, 29% withheld (85% of the company cast a for/withheld vote).

The 82 asset managers below cast 100% of the shares they voted on this item FOR (20,412,564 for, 0 against).

FOR 70%ABSTAIN 30%

FOR: 20,412,564 (70.4%)ABSTAIN: 8,592,742 (29.6%)

Largest asset managers voting on “Election of Class I Directors: Nelson Chan” at TWIST BIOSCIENCE CORP., 2024-2025
Asset manager	For	Abstain	Vote
Vanguard	5,604,178	0	For
ARK ETF Trust	5,467,381	0	For
Invesco	0	2,265,036	Abstain
BlackRock	1,975,800	0	For
Artisan	1,940,297	0	For
Fidelity	1,496,978	0	For
Thrivent	0	1,492,461	Abstain
State Street	815,271	912	For
JPMorgan	725,666	0	For
Bridge Builder Trust	532,727	159,712	For
ALGER FUNDS	0	658,990	Abstain
WILLIAM BLAIR FUNDS	0	643,399	Abstain
American Century	0	598,483	Abstain
Charles Schwab	541,843	0	For
Dimensional	0	453,797	Abstain
Jackson National	0	425,440	Abstain
TIAA	247,992	0	For
BNY Mellon	239,125	3,516	For
Brighthouse	0	221,698	Abstain
Victory Capital	0	210,512	Abstain
OPTIMUM FUND TRUST	0	202,500	Abstain
MassMutual	0	195,723	Abstain
AIG/SunAmerica	0	167,303	Abstain
Equitable	93,314	64,904	For
Voya	0	114,490	Abstain

Showing the 25 largest of 82 asset managers. See all 82 in the interactive database.

5. Election of Class I Directors: Robert Ragusa

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 5 wordings of this item as funds reported it.

79% Majority: yes · of votes cast

FOR 79%WITHHELD 21%

FOR: 40,170,187WITHHELD: 10,648,111

TWIST BIOSCIENCE CORP.’s own tally for this item (“Elect Director: Robert Ragusa”): 40,170,187 for, 10,648,111 withheld, per its Form 8-K filed 2025-02-11 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 59,582,000 outstanding shares: 67% for, 18% withheld (85% of the company cast a for/withheld vote).

The 82 asset managers below cast 100% of the shares they voted on this item FOR (23,828,614 for, 0 against).

FOR 82%ABSTAIN 18%

FOR: 23,828,614 (82.2%)ABSTAIN: 5,176,692 (17.8%)

Largest asset managers voting on “Election of Class I Directors: Robert Ragusa” at TWIST BIOSCIENCE CORP., 2024-2025
Asset manager	For	Abstain	Vote
Vanguard	5,604,178	0	For
ARK ETF Trust	5,467,381	0	For
Invesco	2,265,036	0	For
BlackRock	1,975,800	0	For
Artisan	0	1,940,297	Abstain
Fidelity	1,278,568	218,410	For
Thrivent	1,492,461	0	For
State Street	1,539	814,644	Abstain
JPMorgan	725,666	0	For
Bridge Builder Trust	170,982	521,457	Abstain
ALGER FUNDS	658,990	0	For
WILLIAM BLAIR FUNDS	643,399	0	For
American Century	598,483	0	For
Charles Schwab	0	541,843	Abstain
Dimensional	0	453,797	Abstain
Jackson National	417,099	8,341	For
TIAA	247,992	0	For
BNY Mellon	3,516	239,125	Abstain
Brighthouse	214,534	7,164	For
Victory Capital	210,512	0	For
OPTIMUM FUND TRUST	202,500	0	For
MassMutual	171,944	23,779	For
AIG/SunAmerica	167,303	0	For
Equitable	93,314	64,904	For
Voya	114,490	0	For

Showing the 25 largest of 82 asset managers. See all 82 in the interactive database.

6. Election of Class I Directors: Melissa Starovasnik

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 6 wordings of this item as funds reported it.

96% Majority: yes · of votes cast

FOR 96%

FOR: 48,898,476WITHHELD: 1,919,822

TWIST BIOSCIENCE CORP.’s own tally for this item (“Elect Director: Melissa A. Starovasnik, Ph.D.”): 48,898,476 for, 1,919,822 withheld, per its Form 8-K filed 2025-02-11 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 59,582,000 outstanding shares: 82% for, 3% withheld (85% of the company cast a for/withheld vote).

The 82 asset managers below cast 100% of the shares they voted on this item FOR (28,222,855 for, 0 against).

FOR 97%

FOR: 28,222,855 (97.3%)ABSTAIN: 782,451 (2.7%)

Largest asset managers voting on “Election of Class I Directors: Melissa Starovasnik” at TWIST BIOSCIENCE CORP., 2024-2025
Asset manager	For	Abstain	Vote
Vanguard	5,604,178	0	For
ARK ETF Trust	5,467,381	0	For
Invesco	2,265,036	0	For
BlackRock	1,975,800	0	For
Artisan	1,940,297	0	For
Fidelity	1,496,978	0	For
Thrivent	1,492,461	0	For
State Street	816,125	58	For
JPMorgan	725,666	0	For
Bridge Builder Trust	692,439	0	For
ALGER FUNDS	658,990	0	For
WILLIAM BLAIR FUNDS	643,399	0	For
American Century	598,483	0	For
Charles Schwab	541,843	0	For
Dimensional	0	453,797	Abstain
Jackson National	417,099	8,341	For
TIAA	247,992	0	For
BNY Mellon	3,516	239,125	Abstain
Brighthouse	214,534	7,164	For
Victory Capital	210,512	0	For
OPTIMUM FUND TRUST	202,500	0	For
MassMutual	195,723	0	For
AIG/SunAmerica	167,303	0	For
Equitable	93,314	64,904	For
Voya	114,490	0	For

Showing the 25 largest of 82 asset managers. See all 82 in the interactive database.

7. To approve an amendment to the Company's Amended and Restated Certificate of Incorporation (the "Charter") to increase the number of shares of common stock of the Company authorized thereunder by an additional 100,000,000 shares.

COMPENSATION

Combines 3 wordings of this item as funds reported it.

99.8% fund support · no official result

FOR 99.8%

The 82 asset managers below cast 99.8% of the shares they voted on this item FOR (29,616,700 for, 33,692 against).

FOR: 29,616,700 (99.9%)AGAINST: 33,692 (0.1%)

Largest asset managers voting on “To approve an amendment to the Company's Amended and Restated Certificate of Incorporation (the "Charter") to ” at TWIST BIOSCIENCE CORP., 2024-2025
Asset manager	For	Against	Vote
Vanguard	5,604,178	0	For
ARK ETF Trust	5,467,381	0	For
Invesco	2,265,036	0	For
BlackRock	1,975,800	0	For
Artisan	1,940,297	0	For
Fidelity	1,496,978	0	For
Thrivent	1,492,461	0	For
First Light Asset Management, LLC	857,427	0	For
State Street	816,155	28	For
JPMorgan	725,666	0	For
Bridge Builder Trust	692,439	0	For
ALGER FUNDS	658,990	0	For
WILLIAM BLAIR FUNDS	643,399	0	For
American Century	598,483	0	For
Charles Schwab	541,843	0	For
Dimensional	453,797	0	For
Jackson National	425,440	0	For
TIAA	247,992	0	For
BNY Mellon	242,641	0	For
Victory Capital	210,512	0	For
OPTIMUM FUND TRUST	202,500	0	For
MassMutual	195,723	0	For
AIG/SunAmerica	167,303	0	For
Equitable	158,218	0	For
Voya	114,490	0	For

Showing the 25 largest of 82 asset managers. See all 82 in the interactive database.

8. To ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending September 30, 2025.

AUDIT-RELATED

Combines 2 wordings of this item as funds reported it.

100% fund support · no official result

FOR 99.9%

The 82 asset managers below cast 100% of the shares they voted on this item FOR (28,806,991 for, 0 against).

FOR: 28,806,991 (100.0%)ABSTAIN: 7,164 (0.0%)

Largest asset managers voting on “To ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm for the fi” at TWIST BIOSCIENCE CORP., 2024-2025
Asset manager	For	Vote
Vanguard	5,604,178	For
ARK ETF Trust	5,467,381	For
Invesco	2,265,036	For
BlackRock	1,975,800	For
Artisan	1,940,297	For
Fidelity	1,496,978	For
Thrivent	1,492,461	For
State Street	816,183	For
JPMorgan	725,666	For
Bridge Builder Trust	692,439	For
ALGER FUNDS	658,990	For
WILLIAM BLAIR FUNDS	643,399	For
American Century	598,483	For
Charles Schwab	541,843	For
Dimensional	453,797	For
Jackson National	425,440	For
TIAA	247,992	For
BNY Mellon	242,641	For
Victory Capital	210,512	For
OPTIMUM FUND TRUST	202,500	For
MassMutual	195,723	For
AIG/SunAmerica	167,303	For
Equitable	158,218	For
Voya	114,490	For
Columbia Threadneedle	104,559	For

Showing the 25 largest of 82 asset managers. See all 82 in the interactive database.

9. Advisory Vote to Ratify Named Executive Officers' Compensation

SECTION 14A SAY-ON-PAY VOTES

99.9% fund support · no official result

FOR 99.9%

The 6 asset managers below cast 99.9% of the shares they voted on this item FOR (1,803,450 for, 494 against).

FOR: 1,803,450 (100.0%)AGAINST: 494 (0.0%)

Largest asset managers voting on “Advisory Vote to Ratify Named Executive Officers' Compensation” at TWIST BIOSCIENCE CORP., 2024-2025
Asset manager	For	Against	Vote
JPMorgan	1,609,146	0	For
Brighthouse	193,289	0	For
HC CAPITAL TRUST	574	0	For
Desjardins Global Asset Management Inc.	0	494	Against
Vinva Investment Management Ltd	229	0	For
TD ASSET MANAGEMENT INC	212	0	For

10. Amend Omnibus Stock Plan

COMPENSATION

99.7% fund support · no official result

FOR 99.7%

The 2 asset managers below cast 99.7% of the shares they voted on this item FOR (193,289 for, 574 against).

FOR: 193,289 (99.7%)AGAINST: 574 (0.3%)

Largest asset managers voting on “Amend Omnibus Stock Plan” at TWIST BIOSCIENCE CORP., 2024-2025
Asset manager	For	Against	Abstain	Withheld	Vote
Brighthouse	193,289	0	0	0	For
HC CAPITAL TRUST	0	574	0	0	Against

11. Increase Authorized Common Stock

CAPITAL STRUCTURE

100% fund support · no official result

FOR 100%

The 2 asset managers below cast 100% of the shares they voted on this item FOR (193,863 for, 0 against).

FOR: 193,863 (100.0%)

Largest asset managers voting on “Increase Authorized Common Stock” at TWIST BIOSCIENCE CORP., 2024-2025
Asset manager	For	Against	Abstain	Withheld	Vote
Brighthouse	193,289	0	0	0	For
HC CAPITAL TRUST	574	0	0	0	For

12. Ratify Ernst & Young LLP as Auditors

AUDIT-RELATED

100% fund support · no official result

FOR 100%

The 2 asset managers below cast 100% of the shares they voted on this item FOR (193,863 for, 0 against).

FOR: 193,863 (100.0%)

Largest asset managers voting on “Ratify Ernst & Young LLP as Auditors” at TWIST BIOSCIENCE CORP., 2024-2025
Asset manager	For	Against	Abstain	Withheld	Vote
Brighthouse	193,289	0	0	0	For
HC CAPITAL TRUST	574	0	0	0	For

Largest TWIST BIOSCIENCE CORP. shareholders voting in 2024-2025

Ranked by the number of TWIST BIOSCIENCE CORP. shares each manager voted on the most widely held ballot item of the 2024-2025 meeting, shown as a share of the 59,582,000 shares outstanding at the time of that meeting.

Top TWIST BIOSCIENCE CORP. shareholders by shares voted, 2024-2025
#	Asset manager	% of shares outstanding
1	Artisan	11.13%
2	Vanguard	9.81%
3	ARK ETF Trust	9.18%
4	Invesco	8.22%
5	BlackRock	5.72%
6	Thrivent	5.03%
7	State Street	4.71%
8	Nikko Asset Management Co., Ltd.	4.41%
9	WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC	3.95%
10	Fidelity	2.89%

Reported TWIST BIOSCIENCE CORP. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

TWIST BIOSCIENCE CORP. beneficial owners on record for the 2024-2025 proxy season
Holder	% outstanding	Disclosure
ARK Investment Management LLC	10.65%	13G
Artisan Partners Asset Management Inc.	10.43%	13G
Artisan Partners Limited Partnership	10.19%	DEF14A
BlackRock	9.45%	13F
The Vanguard Group	9.19%	DEF14A
EdgePoint Investment Group Inc.	9.03%	13G
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC	8.84%	13G
Invesco	5.68%	13F
STATE STREET CORPORATION	5.18%	13G
JPMorgan Chase	2.44%	13F

Percentages above are of 59,582,000 shares outstanding, as reported by TWIST BIOSCIENCE CORP. on its Form 10-Q dated 2024-12-31 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from TWIST BIOSCIENCE CORP.’s 10-Q dated 2024-12-31. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At TWIST BIOSCIENCE CORP.'s shareholder meeting held 2025-02-05, in the 2024-2025 proxy season, 292 asset managers reported how they voted in their SEC Form N-PX filings, covering 2,639 separate fund positions. Their filings are grouped here into 12 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. TWIST BIOSCIENCE CORP.'s own Form 8-K tally for this meeting is published below, but no row in it could be matched to the most widely held item, so this page states no certified outcome for that item. On that item — To adopt, on an advisory basis, a resolution approving the compensation of the Company's Named… — the reporting funds cast 98% of the shares they voted in favour (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). That is the aggregate of those managers' own N-PX disclosures, not the company's certified result, and the funds are a subset of all shareholders.

TWIST BIOSCIENCE CORP. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.